Publication Name	World Journal of Gastroenterology
Manuscript ID	27166
Country	Germany

Received	2016-05-15 18:07
Peer-Review Started	2016-05-17 16:06
To Make the First Decision	2016-07-12 16:12
Return for Revision	2016-07-14 17:30
Revised	2016-08-09 19:53
Second Decision	2016-10-12 11:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-10-19 17:08
Articles in Press	2016-10-19 17:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-10-24 11:48
Publish the Manuscript Online	2016-11-06 15:43

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Manuscript Source	Invited Manuscript
All Author List	Nina Weiler, Stefan Zeuzem and Martin-Walter Welker
Funding Agency and Grant Number
Corresponding Author	Martin-Walter Welker, MD, Univer­sitätsklinikum Frankfurt, Medizinische Klinik 1, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. welker@med.uni-frankfurt.de
Key Words	hepatitis C; Cirrhosis; Liver transplantation; Direct antiviral agents; Interferon-free antiviral treatment
Core Tip	Chronic hepatitis C is a major reason for development of cirrhosis and a leading cause for liver transplantation. The development of direct-acting antiviral agents (DAA) offered new therapeutic options for patients with advanced cirrhosis and liver graft recipients. This review gives a high topical summary of most current therapeutic options of DAA-based antiviral therapy in patients with hepatitis C virus associated cirrhosis before and after liver transplantation.
Publish Date	2016-11-06 15:43
Citation	Weiler N, Zeuzem S, Welker MW. Concise review: Interferon-free treatment of hepatitis c virus-associated cirrhosis and liver graft infection. World J Gastroenterol 2016; 22(41): 9044-9056
URL	http://www.wjgnet.com/1007-9327/full/v22/i41/9044.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i41.9044

Full Article (PDF)	WJG-22-9044.pdf
Full Article (Word)	WJG-22-9044.doc
Manuscript File	27166-Review.doc
Answering Reviewers	27166-Answering reviewers.pdf
Audio Core Tip	27166-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	27166-Conflict-of-interest statement.pdf
Copyright License Agreement	27166-Copyright assignment.pdf
Peer-review Report	27166-Peer-review(s).pdf
Scientific Misconduct Check	27166-Scientific misconduct check.pdf
Scientific Editor Work List	27166-Scientific editor work list.pdf